Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 6, Pages e20947
Publisher
Public Library of Science (PLoS)
Online
2011-06-18
DOI
10.1371/journal.pone.0020947
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Biological Activity of Human Anti-Apical Membrane Antigen-1 Antibodies Induced by Natural Infection and Vaccination
- (2014) K. Miura et al. JOURNAL OF IMMUNOLOGY
- Interaction betweenPlasmodium falciparumApical Membrane Antigen 1 and the Rhoptry Neck Protein Complex Defines a Key Step in the Erythrocyte Invasion Process of Malaria Parasites
- (2010) Dave Richard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
- (2010) Mahamadou A. Thera et al. PLoS One
- Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein
- (2009) Lilin Zhong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
- (2009) K. Miura et al. Clinical and Vaccine Immunology
- In Vitro Growth-Inhibitory Activity and Malaria Risk in a Cohort Study in Mali
- (2009) P. D. Crompton et al. INFECTION AND IMMUNITY
- Malaria: a research agenda for the eradication era
- (2009) Wen Kilama et al. LANCET
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
- (2009) Michele D. Spring et al. PLoS One
- High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
- (2009) Sheetij Dutta et al. PLoS One
- Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity
- (2009) P. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
- (2009) Ruth D. Ellis et al. VACCINE
- A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
- (2009) Issaka Sagara et al. VACCINE
- A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
- (2009) Issaka Sagara et al. VACCINE
- Functional Analysis of the Leading Malaria Vaccine Candidate AMA-1 Reveals an Essential Role for the Cytoplasmic Domain in the Invasion Process
- (2009) Moritz Treeck et al. PLoS Pathogens
- An Inhibitory Antibody Blocks Interactions between Components of the Malarial Invasion Machinery
- (2009) Christine R. Collins et al. PLoS Pathogens
- Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
- (2008) Alassane Dicko et al. PLoS One
- Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
- (2008) Mahamadou A. Thera et al. PLoS One
- Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
- (2008) Gregory E. D. Mullen et al. PLoS One
- Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
- (2008) Meta Roestenberg et al. PLoS One
- Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults
- (2008) Arlene E. Dent et al. PLoS One
- Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: Implications for vaccine design
- (2008) J. Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Apical membrane antigen 1: a malaria vaccine candidate in review
- (2008) Edmond J. Remarque et al. TRENDS IN PARASITOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started